Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation

Stem Cells Translational Medicine

Volumn 3, Issue 7, 2014, Pages 809-820

  Baulier, Edouard ^a,b   Favreau, Frederic ^a,b   Le Corf, Amélie ^b,c   Jayle, Christophe ^a,b   Schneider, Fabrice ^b   Goujon, Jean Michel ^a,b   Feraud, Olivier ^c   Bennaceur Griscelli, Annelise ^c   Hauet, Thierry ^a,b,d   Turhan, Ali G ^b,c  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Centre National de la Recherche Scientifique   (France)

^d CEMAGREF   (France)

Author keywords

Amniotic fluid derived mesenchymal stem cells; Deceased after cardiac arrest donors; Ischemia reperfusion injury; Kidney transplantation; Pig; Preclinical model

Indexed keywords

4', 6 DIAMIDINO 2 PHENYLINDOLE; 5' NUCLEOTIDASE; 7 AMINODACTINOMYCIN; ALPHA SMOOTH MUSCLE ACTIN; ANGIOPOIETIN 1; BETA ACTIN; BETA1 INTEGRIN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CREATININE; ELONGATION FACTOR 1ALPHA; ENDOGLIN; GREEN FLUORESCENT PROTEIN; HERMES ANTIGEN; LENTIVIRUS VECTOR; SODIUM; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

AMNION FLUID; AMNIOTIC FLUID DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL SUSPENSION; CELL TRACKING; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; FLOW CYTOMETRY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY AUTOTRANSPLANTATION; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY PRESERVATION; KIDNEY TUBULE FUNCTION; MESENCHYMAL STEM CELL TRANSPLANTATION; NEPHRECTOMY; NONHUMAN; PROTEIN EXPRESSION; PROTEINURIA; RENAL ARTERY; REOXYGENATION; TISSUE REGENERATION; TUBE FORMATION ASSAY; WESTERN BLOTTING; XTT ASSAY;

AMNIOTIC FLUID-DERIVED MESENCHYMAL STEM CELLS; DECEASED AFTER CARDIAC ARREST DONORS; ISCHEMIA REPERFUSION INJURY; KIDNEY TRANSPLANTATION; PIG; PRECLINICAL MODEL;

AMNIOTIC FLUID; ANIMALS; CELL TRACKING; CELLS, CULTURED; FEMALE; FIBROSIS; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; KIDNEY; KIDNEY TRANSPLANTATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MULTIPOTENT STEM CELLS; PREGNANCY; RECOVERY OF FUNCTION; REPERFUSION INJURY; SWINE; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSFECTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84903537557     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0186     Document Type: Article

References (42)

1. Dragun D, Hoff U, Park JK et al. Ischemiareperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 2000; 58: 2166-2177.
2. Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med 2011; 17: 1391-1401.
3. Cicco G, Panzera PC, Catalano G et al. Microcirculation and reperfusion injury in organ transplantation. Adv Exp Med Biol 2005; 566: 363-373.
4. Basile DP. The endothelial cell in ischemic acute kidney injury: Implications for acute and chronic function. Kidney Int 2007; 72: 151-156.
5. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: A potential factor predisposing to progressive nephropathy. Curr Opin Nephrol Hypertens 2004; 13: 1-7.
6. Metcalfe MS, Butterworth PC, White SA et al. A case-control comparison of the results of renal transplantation from heart-beating and non-heart-beating donors. Transplantation 2001; 71: 1556-1559.
7. Koffman G, Gambaro G. Renal transplantation from non-heart-beating donors: A review of the European experience. J Nephrol 2003; 16: 334-341.
8. Reinders ME, de Fijter JW, Roelofs H et al. Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: Results of a phase I study. STEM CELLS TRANSLATIONAL MEDICINE 2013; 2: 107-111.
9. Ren G, Chen X, Dong F et al. Concise review: Mesenchymal stem cells and translational medicine: Emerging issues. STEM CELLS TRANSLATIONAL MEDICINE 2012; 1: 51-58.
10. Giraud S, Favreau F, Chatauret N et al. Contribution of large pig for renal ischemiareperfusion and transplantation studies: The preclinical model. J Biomed Biotechnol 2011; 532127.
11. Perin L, Giuliani S, Jin D et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007; 40: 936-948.
12. De Coppi P, Bartsch G Jr., Siddiqui MM et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007; 25: 100-106.
13. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. STEM CELLS 2004; 22: 1338-1345.
14. Perin L, Sedrakyan S, Giuliani S et al. Protective effect of humanamniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 2010; 5: e9357.
15. Hauser PV, De Fazio R, Bruno S et al. Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 2010; 177: 2011-2021.
16. Sedrakyan S, Da Sacco S, Milanesi A et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol 2012; 23: 661-673.
17. Jayle C, Favreau F, Zhang K et al. Comparison of protective effects of trimetazidine against experimental warm ischemia of different durations: Early and long-term effects in a pig kidney model. Am J Physiol Renal Physiol 2007; 292: F1082-F1093.
18. Rossard L, Favreau F, Demars J et al. Evaluation of early regenerative processes in a preclinical pig model of acute kidney injury. Curr Mol Med 2012; 12: 502-505.
19. Chen J, Lu Z, Cheng D et al. Isolation and characterization of porcine amniotic fluidderived multipotent stem cells. PLoS One 2011; 6: e19964.
20. Bottai D, Cigognini D, Nicora E et al. Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations. Restor Neurol Neurosci 2012; 30: 55-68.
21. Skardal A, Mack D, Kapetanovic E et al. Bioprinted amniotic fluid-derived stem cells accelerate healing of large skin wounds. STEMCELLS TRANSLATIONAL MEDICINE 2012; 1: 792-802.
22. Zhang P, Baxter J, Vinod K et al. Endothelial differentiation of amniotic fluid-derived stem cells: Synergism of biochemical and shear force stimuli. Stem Cells Dev 2009; 18: 1299-1308.
23. Da Sacco S, Sedrakyan S, Boldrin F et al. Human amniotic fluid as a potential new source of organ specific precursor cells for future regenerative medicine applications. J Urol 2010; 183: 1193-1200.
24. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
25. Bai J, Wang Y, Liu L et al. Human amniotic fluid-derived c-kit(+) and c-kit(-) stem cells: Growth characteristics and some differentiation potential capacities comparison. Cytotechnology 2012; 64: 577-589.
26. Van Raemdonck D, Neyrinck A, Rega F et al. Machine perfusion in organ transplantation: A tool for ex-vivo graft conditioning with mesenchymal stem cells? Curr Opin Organ Transplant 2013; 18: 24-33.
27. Anders HJ, Vielhauer V, Schlöndorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 2003; 63: 401-415.
28. PescovitzMD, Lunney JK, Sachs DH. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol 1984; 133: 368-375.
29. Banfi A, von Degenfeld G, Blau HM. Critical role of microenvironmental factors in angiogenesis. Curr Atheroscler Rep 2005; 7: 227-234.
30. Horie N, Pereira MP, Niizuma K et al. Transplanted stem cell-secreted VEGF effects post-stroke recovery, inflammation, and vascular repair. STEM CELLS 2011; 29: 274-285.
31. Wu Y, Chen L, Scott PG et al. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. STEM CELLS 2007; 25: 2648-2659.
32. Woolf AS, Gnudi L, Long DA. Roles of angiopoietins in kidney development and disease. J Am Soc Nephrol 2009; 20: 239-244.
33. Autiero M, Waltenberger J, Communi D et al. Role of PlGF in the intra-and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 2003; 9: 936-943.
34. Luttun A, Tjwa M, MoonsL et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8: 831-840.
35. Li XD, Chen J, Ruan CC et al. Vascular endothelial growth factor-induced osteopontin expression mediates vascular inflammation and neointima formation via Flt-1 in adventitial fibroblasts. Arterioscler Thromb Vasc Biol 2012; 32: 2250-2258.
36. Kasper G, Dankert N, Tuischer J et al. Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. STEM CELLS 2007; 25: 903-910.
37. van Meeteren LA, ten Dijke P. Regulation of endothelial cell plasticity by TGF-bCell Tissue Res 2012; 347: 177-186.
38. Schmidt-Weber CB, Blaser K. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. Curr Opin Immunol 2004; 16: 709-716.
39. ten Dijke P, Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007; 8: 857-869.
40. Melief SM, Schrama E, Brugman MH et al. Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes towards antiinflammatory macrophages. STEM CELLS 2013; 31: 1980-1991.
41. Fei X, Jiang S, Zhang S et al. Isolation, culture, and identification of amniotic fluidderived mesenchymal stem cells. Cell Biochem Biophys 2013; 67: 689-694.
42. Chien KR. Stem cells: Lost in translation. Nature 2004; 428: 607-608.